CPG
VIR icon

Cornerstone Planning Group’s Vir Biotechnology VIR Stock Holding History

Cornerstone Planning Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Hold
100
– – ﹤0.01% 1462
2025
Q4 		$757 Buy
100
+87
+669% +$518 ﹤0.01% 1407
2025
Q3 		$450 Sell
13
-87
-87% -$445 ﹤0.01% 1505
2025
Q2 		$511 Hold
100
– – ﹤0.01% 1295
2025
Q1 		$597 Hold
100
– – ﹤0.01% 1250
2024
Q4 		$1.03K Hold
100
– – ﹤0.01% 946
2024
Q3 		$761 Hold
100
– – ﹤0.01% 1002
2024
Q2 		$865 Hold
100
– – ﹤0.01% 973
2024
Q1 		$1.04K Hold
100
– – ﹤0.01% 779
2023
Q4 		$1.01K Hold
100
– – ﹤0.01% 715
2023
Q3 		$937 Hold
100
– – ﹤0.01% 799
2023
Q2 		$2.45K Buy
+100
New +$2.51K ﹤0.01% 1099
2022
Q4 		$2.69K Buy
+100
New +$2.45K ﹤0.01% 1113

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Cornerstone Planning Group's VIR Position: Q1 2026 in Review

Cornerstone Planning Group held its Vir Biotechnology (VIR) position steady in Q1 2026 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Cornerstone Planning Group first reported a position in VIR in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.69K in Q4 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Cornerstone Planning Group held 100 shares of Vir Biotechnology worth $1K as of Q1 2026.
  • Cornerstone Planning Group left its Vir Biotechnology share count unchanged in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #1462 holding.
  • Cornerstone Planning Group first reported a position in Vir Biotechnology in Q4 2022 and has held it in 13 quarters since.
  • Cornerstone Planning Group's Vir Biotechnology position peaked at $2.69K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.